Proton Pump Inhibitors Display Anti-tumour Potential in Glioma

Overview

Journal Cell Prolif

Date 2022 Aug 12

PMID 35961680

Authors

Bihan Li

Ying Liu

Shilong Sun

Affiliations

Soon will be listed here.

Abstract

Objectives: Glioma is one of the most aggressive brain tumours with poor overall survival despite advanced technology in surgical resection, chemotherapy and radiation. Progression and recurrence are the hinge causes of low survival. Our aim is to explain the concrete mechanism in the proliferation and progression of tumours based on tumour microenvironment (TME). The main purpose is to illustrate the mechanism of proton pump inhibitors (PPIs) in affecting acidity, hypoxia, oxidative stress, inflammatory response and autophagy based on the TME to induce apoptosis and enhance the sensitivity of chemoradiotherapy.

Findings: TME is the main medium for tumour growth and progression. Acidity, hypoxia, inflammatory response, autophagy, angiogenesis and so on are the main causes of tumour progress. PPIs, as a common clinical drug to inhibit gastric acid secretion, have the advantages of fast onset, long action time and small adverse reactions. Nowadays, several kinds of literature highlight the potential of PPIs in inhibiting tumour progression. However, long-term use of PPIs alone also has obvious side effects. Therefore, till now, how to apply PPIs to promote the effect of radio-chemotherapy and find the concrete dose and concentration of combined use are novel challenges.

Conclusions: PPIs display the potential in enhancing the sensitivity of chemoradiotherapy to defend against glioma based on TME. In the clinic, it is also necessary to explore specific concentrations and dosages in synthetic applications.

Citing Articles

Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy.

Rahman M, Yadab M, Ali M Cells. 2024; 13(22).

PMID: 39594672 PMC: 11592846. DOI: 10.3390/cells13221924.

Proton pump inhibitor attenuates acidic microenvironment to improve the therapeutic effects of MSLN-CAR-T cells on the brain metastasis.

Zhai X, Mao L, Kang Q, Liu J, Zhou Y, Wang J Mol Ther. 2024; 33(1):336-355.

PMID: 39511890 PMC: 11764123. DOI: 10.1016/j.ymthe.2024.11.010.

Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence.

Sawaid I, Samson A J Clin Med. 2024; 13(7).

PMID: 38610738 PMC: 11012754. DOI: 10.3390/jcm13071970.

Proton pump inhibitors display anti-tumour potential in glioma.

Li B, Liu Y, Sun S Cell Prolif. 2022; 56(7):e13321.

PMID: 35961680 PMC: 10334276. DOI: 10.1111/cpr.13321.

References

Tomita K, Kuwahara Y, Igarashi K, Roudkenar M, Roushandeh A, Kurimasa A . Mitochondrial Dysfunction in Diseases, Longevity, and Treatment Resistance: Tuning Mitochondria Function as a Therapeutic Strategy. Genes (Basel). 2021; 12(9). PMC: 8467098. DOI: 10.3390/genes12091348. View

Zhou Y, Wang W, Chen N, Wang L, Huang J . Research progress of anti-glioma chemotherapeutic drugs (Review). Oncol Rep. 2022; 47(5). PMC: 8990335. DOI: 10.3892/or.2022.8312. View

Cheng F, Ho Y, Hung L, Chen C, Tsai T . Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography. J Chromatogr A. 2002; 949(1-2):35-42. DOI: 10.1016/s0021-9673(01)01225-0. View

Lee Y, Jeon H, Hong J, Cho Y, Ryu J, Choi J . Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma. Oncotarget. 2015; 6(33):35040-50. PMC: 4741507. DOI: 10.18632/oncotarget.5319. View

Demuynck R, Efimova I, Naessens F, Krysko D . Immunogenic ferroptosis and where to find it?. J Immunother Cancer. 2021; 9(12). PMC: 8671998. DOI: 10.1136/jitc-2021-003430. View

Boj-Carceller D . Proton pump inhibitors: impact on glucose metabolism. Endocrine. 2012; 43(1):22-32. DOI: 10.1007/s12020-012-9755-3. View

Weijenborg P, Smout A, Bredenoord A . Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn. Neurogastroenterol Motil. 2016; 28(11):1649-1654. DOI: 10.1111/nmo.12864. View

Kulkarni P, Haldar M, Katti P, Dawes C, You S, Choi Y . Hypoxia Responsive, Tumor Penetrating Lipid Nanoparticles for Delivery of Chemotherapeutics to Pancreatic Cancer Cell Spheroids. Bioconjug Chem. 2016; 27(8):1830-8. PMC: 5502747. DOI: 10.1021/acs.bioconjchem.6b00241. View

Hebert K, Jaramillo S, Yu W, Wang M, Veeramachaneni R, Sandulache V . Esomeprazole enhances the effect of ionizing radiation to improve tumor control. Oncotarget. 2021; 12(14):1339-1353. PMC: 8274720. DOI: 10.18632/oncotarget.28008. View

10.

Ieraci L, Eberg M, Forster K, Murray P, Borg E, Habbous S . Development of population-level colon cancer pathway concordance measures and association with survival. Int J Cancer. 2022; 150(12):2046-2057. PMC: 9311776. DOI: 10.1002/ijc.33964. View

11.

Qi C, Lei L, Hu J, Wang G, Liu J, Ou S . Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations. Cell Cycle. 2022; 21(12):1294-1315. PMC: 9132400. DOI: 10.1080/15384101.2022.2049157. View

12.

Li J, Zhao L, Zhang Y, Li W, Duan X, Chen J . Imbalanced immune responses involving inflammatory molecules and immune-related pathways in the lung of acute and subchronic arsenic-exposed mice. Environ Res. 2017; 159:381-393. DOI: 10.1016/j.envres.2017.08.036. View

13.

Babu D, Mudiraj A, Yadav N, Y B V K C, Panigrahi M, Prakash Babu P . Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition. Cell Oncol (Dordr). 2021; 44(4):889-905. DOI: 10.1007/s13402-021-00609-w. View

14.

Sporikova Z, Slavkovsky R, Tuckova L, Kalita O, Megova Houdova M, Ehrmann J . IDH1/2 Mutations in Patients With Diffuse Gliomas: A Single Centre Retrospective Massively Parallel Sequencing Analysis. Appl Immunohistochem Mol Morphol. 2022; 30(3):178-183. PMC: 8920008. DOI: 10.1097/PAI.0000000000000997. View

15.

Arnoux A, Bailhache M, Tetard C, Rebouissoux L, Clouzeau H, Lamireau T . Proton pump inhibitors are still overprescribed for hospitalized children. Arch Pediatr. 2022; 29(4):258-262. DOI: 10.1016/j.arcped.2022.02.004. View

16.

Xi X, Wang J, Qin Y, You Y, Huang W, Zhan J . The Biphasic Effect of Flavonoids on Oxidative Stress and Cell Proliferation in Breast Cancer Cells. Antioxidants (Basel). 2022; 11(4). PMC: 9032920. DOI: 10.3390/antiox11040622. View

17.

Wedekind H, Walz K, Buchbender M, Rieckmann T, Strasser E, Grottker F . Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages. Strahlenther Onkol. 2021; 198(2):171-182. PMC: 8789708. DOI: 10.1007/s00066-021-01856-4. View

18.

Jimenez L, Campos Codo A, Sampaio V, Oliveira A, Ferreira L, Davanzo G . Acid pH Increases SARS-CoV-2 Infection and the Risk of Death by COVID-19. Front Med (Lausanne). 2021; 8:637885. PMC: 8417536. DOI: 10.3389/fmed.2021.637885. View

19.

Lee H, Park J, Han Y, Gil H, Kim J, Chang J . The role of chronic inflammation in the development of gastrointestinal cancers: reviewing cancer prevention with natural anti-inflammatory intervention. Expert Rev Gastroenterol Hepatol. 2015; 10(1):129-39. DOI: 10.1586/17474124.2016.1103179. View

20.

Park J, Jeong J, Bae Y . Protein Kinase CK2 Is Upregulated by Calorie Restriction and Induces Autophagy. Mol Cells. 2021; 45(3):112-121. PMC: 8926869. DOI: 10.14348/molcells.2021.0183. View